PATENTS RELATED TO HORMONES

Although Dr. Demchick also represents patent seekers with non-biological inventions, his doctorate is in biology. Biology has been the primary focus of his research and teaching. He especially loves dealing with patent searches and applications for involving biology.

Dr. Demchick is a scientist with a quarter of a century of research experience in academic, industrial and governmental settings.

If you are considering patent protection for an invention, Dr. Demchick will be glad to discuss the matter with you. There is no charge for an initial discussion.

The following sampling is to give you some sense of the types of hormones related inventions which have received United States patent protection. The patent list is not exhaustive and is certainly not a substitute for a proper patent search . It should be noted that only U.S. Patents are included.

It should be noted that spelling, form and typographical errors in the original patents are preserved here.

Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) (United States Patent 7,153,951)

Derivatives of growth hormone and related proteins, and methods of use thereof (United States Patent 7,153,943)

Luteinizing hormone and follicle stimulating hormone for use in inducing folliculogenesis (United States Patent 7,151,083)

Parathyroid hormone receptor binding method (United States Patent 7,150,974)

Compounds that bind to growth hormone receptor (United States Patent 7,148,193)

Dog melanin-concentrating hormone receptor (United States Patent 7,148,026)

Compositions for preventing hormone induced adverse effects (United States Patent 7,144,586)

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function (United States Patent 7,141,578)

Prevention of hyperinsulinemia in subjects undergoing growth hormone (GH) treatment (United States Patent 7,141,548)

Monkey and canine melanin concentrating hormone receptors (United States Patent 7,141,391)

Insulinotropic hormone derivatives and uses thereof (United States Patent 7,138,486)

6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH) (United States Patent 7,132,442)

DNA encoding parathyroid hormone receptor (United States Patent 7,132,260)

Substituted dipeptides as growth hormone secretagogues (United States Patent 7,125,840)

Parathyroid hormone receptor ligands (United States Patent 7,122,624)

Eye treatments using synthetic thyroid hormone compositions (United States Patent 7,122,579)

Melanin concentrating hormone antagonist (United States Patent 7,115,750)

Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity (United States Patent 7,109,207)

Bovine growth hormone recombinantly produced in E. coli (United States Patent 7,101,981)

Nuclear hormone receptor drug screens (United States Patent 7,101,681)

Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptors (United States Patent 7,098,310)

Polypeptide hormone phosphatonin (United States Patent 7,098,185)

Low molecular weight peptidomimetic growth hormone secretagogues (United States Patent 7,094,869)

Sampling assembly for simultaneously testing a liquid biological sample for a plurality of hormones and method thereof (United States Patent 7,090,802)

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function (United States Patent 7,087,636)

Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component (United States Patent 7,087,248)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 7,081,459)

Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues (United States Patent 7,081,458)

Long-acting follicle stimulating hormone analogues and uses thereof (United States Patent 7,081,446)

Chicken growth hormone releasing hormone receptor (United States Patent 7,078,514)

Melanin concentrating hormone receptors (United States Patent 7,078,484)

Low dose estrogen interrupted hormone replacement therapy (United States Patent 7,078,394)

Melanin concentrating hormone receptors (United States Patent 7,078,187)

Two gonadotropin releasing hormones and a method to isolate the same (United States Patent 7,074,758)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 7,071,200)

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor (United States Patent 7,071,182)

Variants of corticotropin releasing hormone receptor Type 1 and uses thereof (United States Patent 7,071,161)

Follicle stimulating hormone superagonists (United States Patent 7,070,788)

Use of compounds for decreasing activity of hormone-sensitive lipase (United States Patent 7,067,517)

Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto (United States Patent 7,067,509)

Thyrotropin-releasing hormone analogues and their therapeutic applications (United States Patent 7,067,257)

Stabilized pharmaceutical and thyroid hormone compositions and method of preparation (United States Patent 7,067,148)

Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same (United States Patent 7,060,673)

Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereof (United States Patent 7,060,437)

Hormone receptor functional dimers and methods of their use (United States Patent 7,057,015)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 7,056,927)

Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women (United States Patent 7,056,906)

Hormone and albumin fusion protein (United States Patent 7,056,701)

Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism (United States Patent 7,056,655)

Heterocyclic aromatic compounds useful as growth hormone secreagogues (United States Patent 7,053,110)

Use of biogenic estrogen sulfamates for hormone replacement therapy (United States Patent 7,053,077)

Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof (United States Patent 7,053,045)

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor (United States Patent 7,049,307)

Hormone-sensitive lipase mediated male infertility (United States Patent 7,049,092)

Recombinant fusion proteins to growth hormone and serum albumin (United States Patent 7,045,318)

Pseudopeptides growth hormone secretagogues (United States Patent 7,034,050)

Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders (United States Patent 7,030,113)

Melanin concentrating hormone receptor chimeric and fusion proteins (United States Patent 7,029,878)

Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptors (United States Patent 7,026,125)

Polypeptide derivatives of parathyroid hormone (PTH) (United States Patent 7,022,815)

Amide derivatives as growth hormone secretagogues (United States Patent 7,022,677)

Hormone composition (United States Patent 7,018,992)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 7,015,226)

Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors (United States Patent 7,015,213)

TNF receptor and steroid hormone in a combined therapy (United States Patent 7,012,060)

Fused cyclic modulators of nuclear hormone receptor function (United States Patent 7,001,911)

Sleep inducing toothpaste made with natural herbs and a natural hormone (United States Patent 6,998,112)

Growth hormone secretagogues (United States Patent 6,992,097)

2-Aminoquinolines as melanin concentrating hormone receptor antagonists (United States Patent 6,989,392)

Multifunctional single chain glycoprotein hormones comprising three or more .beta. subunits (United States Patent 6,987,172)

C21 polypeptide that modulates the stability of transcriptional regulatory complexes regulating nuclear hormone receptor activity (United States Patent 6,982,317)

Two gonadotropin releasing hormones and a method to isolate the same (United States Patent 6,977,242)

Heterocyclic aromatic compounds useful as growth hormone secretagogues (United States Patent 6,969,727)

Compositions and methods for increasing growth hormone levels (United States Patent 6,967,206)

Bio-identical hormones and method of use (United States Patent 6,967,194)

Production of human parathyroid hormone from microorganisms (United States Patent 6,962,796)

Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues (United States Patent 6,953,801)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 6,951,858)

Phenyl naphthol ligands for thyroid hormone receptor (United States Patent 6,951,844)

Nucleic acids and proteins with growth hormone activity (United States Patent 6,946,265)

Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities (United States Patent 6,942,980)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 6,939,883)

Compounds with growth hormone releasing properties (United States Patent 6,939,880)

Secretory thyroid stimulating hormone receptor, and method for assaying anti-thyroid stimulating hormone receptor antibody using the same (United States Patent 6,933,364)

Treatment of hypertension using growth hormone in mammals subjected to fetal programming (United States Patent 6,933,278)

Melanin-concentrating hormone antagonist (United States Patent 6,930,185)

Transdermal delivery of hormones (United States Patent 6,923,983)

Cyclase inhibiting parathyroid hormone antagonists or modulators and osteoporosis (United States Patent 6,923,968)

Genes involved in brassinosteroid hormone action in plants (United States Patent 6,921,848)

Antagonists of melanin concentrating hormone receptor (United States Patent 6,921,821)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 6,921,761)

Analogs of parathyroid hormone (United States Patent 6,921,750)

Compounds with growth hormone releasing properties (United States Patent 6,919,315)

Hormone replacement formulation (United States Patent 6,911,438)

Heterocyclic aromatic compounds useful as growth hormone secretagogues (United States Patent 6,908,938)

Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues (United States Patent 6,906,075)

Transdermal therapeutic system containing hormones and crystallization inhibitors (United States Patent 6,899,894)

Growth hormone crystals and a process for production of these GH-crystals (United States Patent 6,894,023)

Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone (United States Patent 6,887,846)

Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) (United States Patent 7,153,951)

Derivatives of growth hormone and related proteins, and methods of use thereof (United States Patent 7,153,943)

Luteinizing hormone and follicle stimulating hormone for use in inducing folliculogenesis (United States Patent 7,151,083)

Parathyroid hormone receptor binding method (United States Patent 7,150,974)

Compounds that bind to growth hormone receptor (United States Patent 7,148,193)

Dog melanin-concentrating hormone receptor (United States Patent 7,148,026)

Compositions for preventing hormone induced adverse effects (United States Patent 7,144,586)

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function (United States Patent 7,141,578)

Prevention of hyperinsulinemia in subjects undergoing growth hormone (GH) treatment (United States Patent 7,141,548)

Monkey and canine melanin concentrating hormone receptors (United States Patent 7,141,391)

Insulinotropic hormone derivatives and uses thereof (United States Patent 7,138,486)

6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH) (United States Patent 7,132,442)

DNA encoding parathyroid hormone receptor (United States Patent 7,132,260)

Substituted dipeptides as growth hormone secretagogues (United States Patent 7,125,840)

Parathyroid hormone receptor ligands (United States Patent 7,122,624)

Eye treatments using synthetic thyroid hormone compositions (United States Patent 7,122,579)

Melanin concentrating hormone antagonist (United States Patent 7,115,750)

Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity (United States Patent 7,109,207)

Bovine growth hormone recombinantly produced in E. coli (United States Patent 7,101,981)

Nuclear hormone receptor drug screens (United States Patent 7,101,681)

Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptors (United States Patent 7,098,310)

Polypeptide hormone phosphatonin (United States Patent 7,098,185)

Low molecular weight peptidomimetic growth hormone secretagogues (United States Patent 7,094,869)

Sampling assembly for simultaneously testing a liquid biological sample for a plurality of hormones and method thereof (United States Patent 7,090,802)

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function (United States Patent 7,087,636)

Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component (United States Patent 7,087,248)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 7,081,459)

Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues (United States Patent 7,081,458)

Long-acting follicle stimulating hormone analogues and uses thereof (United States Patent 7,081,446)

Chicken growth hormone releasing hormone receptor (United States Patent 7,078,514)

Melanin concentrating hormone receptors (United States Patent 7,078,484)

Low dose estrogen interrupted hormone replacement therapy (United States Patent 7,078,394)

Melanin concentrating hormone receptors (United States Patent 7,078,187)

Two gonadotropin releasing hormones and a method to isolate the same (United States Patent 7,074,758)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 7,071,200)

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor (United States Patent 7,071,182)

Variants of corticotropin releasing hormone receptor Type 1 and uses thereof (United States Patent 7,071,161)

Follicle stimulating hormone superagonists (United States Patent 7,070,788)

Use of compounds for decreasing activity of hormone-sensitive lipase (United States Patent 7,067,517)

Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto (United States Patent 7,067,509)

Thyrotropin-releasing hormone analogues and their therapeutic applications (United States Patent 7,067,257)

Stabilized pharmaceutical and thyroid hormone compositions and method of preparation (United States Patent 7,067,148)

Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same (United States Patent 7,060,673)

Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereof (United States Patent 7,060,437)

Hormone receptor functional dimers and methods of their use (United States Patent 7,057,015)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 7,056,927)

Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women (United States Patent 7,056,906)

Hormone and albumin fusion protein (United States Patent 7,056,701)

Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism (United States Patent 7,056,655)

Heterocyclic aromatic compounds useful as growth hormone secreagogues (United States Patent 7,053,110)

Use of biogenic estrogen sulfamates for hormone replacement therapy (United States Patent 7,053,077)

Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof (United States Patent 7,053,045)

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor (United States Patent 7,049,307)

Hormone-sensitive lipase mediated male infertility (United States Patent 7,049,092)

Recombinant fusion proteins to growth hormone and serum albumin (United States Patent 7,045,318)

Pseudopeptides growth hormone secretagogues (United States Patent 7,034,050)

Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders (United States Patent 7,030,113)

Melanin concentrating hormone receptor chimeric and fusion proteins (United States Patent 7,029,878)

Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptors (United States Patent 7,026,125)

Polypeptide derivatives of parathyroid hormone (PTH) (United States Patent 7,022,815)

Amide derivatives as growth hormone secretagogues (United States Patent 7,022,677)

Hormone composition (United States Patent 7,018,992)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 7,015,226)

Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors (United States Patent 7,015,213)

TNF receptor and steroid hormone in a combined therapy (United States Patent 7,012,060)

Fused cyclic modulators of nuclear hormone receptor function (United States Patent 7,001,911)

Sleep inducing toothpaste made with natural herbs and a natural hormone (United States Patent 6,998,112)

Growth hormone secretagogues (United States Patent 6,992,097)

2-Aminoquinolines as melanin concentrating hormone receptor antagonists (United States Patent 6,989,392)

Multifunctional single chain glycoprotein hormones comprising three or more .beta. subunits (United States Patent 6,987,172)

C21 polypeptide that modulates the stability of transcriptional regulatory complexes regulating nuclear hormone receptor activity (United States Patent 6,982,317)

Two gonadotropin releasing hormones and a method to isolate the same (United States Patent 6,977,242)

Heterocyclic aromatic compounds useful as growth hormone secretagogues (United States Patent 6,969,727)

Compositions and methods for increasing growth hormone levels (United States Patent 6,967,206)

Bio-identical hormones and method of use (United States Patent 6,967,194)

Production of human parathyroid hormone from microorganisms (United States Patent 6,962,796)

Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues (United States Patent 6,953,801)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 6,951,858)

Phenyl naphthol ligands for thyroid hormone receptor (United States Patent 6,951,844)

Nucleic acids and proteins with growth hormone activity (United States Patent 6,946,265)

Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities (United States Patent 6,942,980)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 6,939,883)

Compounds with growth hormone releasing properties (United States Patent 6,939,880)

Secretory thyroid stimulating hormone receptor, and method for assaying anti-thyroid stimulating hormone receptor antibody using the same (United States Patent 6,933,364)

Treatment of hypertension using growth hormone in mammals subjected to fetal programming (United States Patent 6,933,278)

Melanin-concentrating hormone antagonist (United States Patent 6,930,185)

Transdermal delivery of hormones (United States Patent 6,923,983)

Cyclase inhibiting parathyroid hormone antagonists or modulators and osteoporosis (United States Patent 6,923,968)

Genes involved in brassinosteroid hormone action in plants (United States Patent 6,921,848)

Antagonists of melanin concentrating hormone receptor (United States Patent 6,921,821)

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (United States Patent 6,921,761)

Analogs of parathyroid hormone (United States Patent 6,921,750)

Compounds with growth hormone releasing properties (United States Patent 6,919,315)

Hormone replacement formulation (United States Patent 6,911,438)

Heterocyclic aromatic compounds useful as growth hormone secretagogues (United States Patent 6,908,938)

Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues (United States Patent 6,906,075)

Transdermal therapeutic system containing hormones and crystallization inhibitors (United States Patent 6,899,894)

Growth hormone crystals and a process for production of these GH-crystals (United States Patent 6,894,023)

Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone (United States Patent 6,887,846)

Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) (United States Patent 7,153,951)

Derivatives of growth hormone and related proteins, and methods of use thereof (United States Patent 7,153,943)

Although his recognition as a registered patent agent permits him to represent others in all patent matters before the United States Patent and Trademark Office, Dr. Demchick limits his practice to patent matters involving inventions for which he is confident that his expertise will allow him to serve his client well. He will gladly discuss whether he is comfortable handling cases involving inventions in a particular field. He will err on the side of declining cases if he has uncertainty about his ability to do what is needed in the case. Dr. Demchick does not represent clients in court. However, he refers clients to a patent attorney who does represent others in court, if it appears likely that patent related representation in court is appropriate. Dr. Demchick prepares and files non-provisional (regular) patent applications and provisional patent applications. He prepares and files utility patent applications and design patent applications. He prepares and files U.S. patent applications and international patent applications under the Patent Cooperation Treaty (PCT). He prepares and files applications to enter the U.S. National Phase for inventions for which international patent applications (PCT) were already filed. One of the matters he discusses with each client or potential client is which type of application(s) best meets that client's needs. He usually does a patent search (patentability search) as part of the preparation of a patent application. He discusses the value of patent searching with each inventor before agreeing to prepare a patent application for that inventor.